<DOC>
	<DOCNO>NCT02543931</DOCNO>
	<brief_summary>The purpose study find whether turmeric dietary supplement available counter general use United States safe useful take specifically treatment rheumatoid arthritis ( RA ) active principle turmeric break metabolized body individual RA .</brief_summary>
	<brief_title>Curcuma Longa L Rheumatoid Arthritis</brief_title>
	<detailed_description>A placebo-controlled , double-blind , three-arm Phase Ib clinical trial assess two dos commercially available curcuminoid formulation enhance bioavailability vs. placebo rheumatoid arthritis ( RA ) population propose . The primary aim clinical planning study determine dose-dependent tolerability enhance bioavailability curcuminoid formulation RA population , include pharmacokinetic analysis , inform design future Phase II trial assess anti-inflammatory efficacy curcuminoids treatment RA . Secondarily , estimate effect size change know biomarkers inflammation RA determine .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Turmeric extract</mesh_term>
	<criteria>Inclusion Criteria Diagnosis RA ( ACR 2010 criterion ) Age &gt; 18 year old Active disease screen visit define : Disease Activity Score [ DAS ] 28 ( 4 ) erythrocyte sedimentation rate ( ESR ) &gt; 3.2 , C reactive protein ( CRP ) &gt; 1.0 mg/dL ESR &gt; 20 . Ability understand willingness sign write informed consent document Current treatment biologic agent ( e.g . tumor necrosis factor ( TNF ) inhibitor : etanercept , infliximab , adalimumab ; interleukin 1 ( IL1 ) inhibitor : anakinra ; lymphocyte direct : abatacept , rituximab ; Janus kinase ( JAK ) inhibitor : tofacitinib ) . Past biologic use allow end &gt; 3 month prior randomization ( &gt; 12 month Rituximab ) History nonresponse biologics . Diseasemodifying antiinflammatory agent ( DMARDs ) , include methotrexate , hydroxychloroquine , sulfasalazine , minocycline , allow stable 1 month prior randomization unchanged throughout study . Leflunomide , gold compound , azathioprine , cyclosporine exclusionary use within month prior randomization . Oral Corticosteroid use &gt; 10 mg/d prednisolone equivalent parenteral corticosteroid dose exclusionary ( 1 month prior randomization final assessment visit ) . Oral corticosteroid low dos ( &lt; 10 mg/d prednisone equivalent ) allow stable 1 month prior randomization unchanged throughout study ) . Topical , inhale , intranasal steroid exclusionary Past parenteral oral ( &gt; 10 mg/d prednisolone equivalent ) corticosteroid allow use within one month prior randomization Nonsteroidal antiinflammatory drug ( NSAID ) exclusionary use continuously &gt; 3 dos 7 day . Enrollment allow washout period 1 week prior randomization use &gt; 3 dos In 7 day ) . Herbal supplement exclusionary . Enrollment allow washout period 1 week prior randomization ) . Patients also ask minimize intake curcuminoidcontaining food entire study period . History positive skin test tuberculosis ( TB ) without treatment . Systemic complication RA ( e.g . vasculitis ) . Recent surgery &lt; 1 month prior , schedule surgery &lt; 2 month randomization History malignancy , superficial basal squamous cell carcinoma skin . History , concurrent , serious chronic infection . Women premenopausal ( woman menses within past 12months ) intact uterus must negative pregnancy test screen randomization , must use medically acceptable form birth control , may breast feeding . Worsening uncontrolled end organ disease intercurrent illness , opinion investigator , may pose added risk patient include , limited , evidence impair renal function , hematological , gastrointestinal , endocrine , pulmonary , cardiac , neurologic psychiatric disease . Acute chronic liver disease , include Gilbert 's syndrome . History atrioventricular ( AV ) nodal conduction defect PR interval ( interval P wave QRS complex ) ECG &gt; 0.2 sec . Use illicit drug high alcohol consumption current/recent ( within past 5 year ) history drug alcohol abuse . Treatment within 28 day randomization another investigational agent , Have history allergic reaction turmeric , Meriva , curcuminoids , include turmericcontaining food curry mustard . Inability difficulty swallow oral medication , malabsorption condition . Inability provide inform consent reason complete simple questionnaire .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>turmeric</keyword>
	<keyword>curcumin</keyword>
	<keyword>curcuminoids</keyword>
	<keyword>arthritis</keyword>
	<keyword>methotrexate</keyword>
</DOC>